Analyst & Firm | Company | Rating | Price Target |
|---|---|---|---|
Celldex | Buy | $56 | |
Lam Research | Buy | $365 | |
Definium Therapeutics | Buy | $78 | |
Abeona Therapeutics | Buy | $17 | |
Contineum Therapeutics, Inc. Class A | Buy | $23 | |
VSE | Buy | ― | |
Cognizant | Buy | $70 | |
California Resources Corp | Buy | $91 | |
Navan, Inc. Class A | Buy | $33 |
Analyst & Firm | Company | Rating | Price Target |
|---|---|---|---|
Celldex | Buy | $56 | |
Lam Research | Buy | $365 | |
Definium Therapeutics | Buy | $78 | |
Abeona Therapeutics | Buy | $17 | |
Contineum Therapeutics, Inc. Class A | Buy | $23 | |
VSE | Buy | ― | |
Cognizant | Buy | $70 | |
California Resources Corp | Buy | $91 | |
Navan, Inc. Class A | Buy | $33 |